Chromosomal microarray
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000521287.3
- Last updated: 2022-10-03
- Test version history
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Autism spectrum disorder
Offered by Genomic Diagnostic Laboratory, Division of Genomic Diagnostics
- NCCN, 2014Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
- ACMG, 2013Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions.
- ISCA, 2010Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
- ACMG, 2008Statement on guidance for genetic counseling in advanced paternal age
- ACMG, 2008Clinical genetics evaluation in identifying the etiology of autism spectrum disorders (See 2013 Update)
- Retired; ACMG, 2005Retired. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.